Should you run Humanin & ARA-290 or Methylene Blue

Stuck between two vials and not sure which one actually earns a spot in your fridge? Should you run Humanin and ARA-290, or reach for Methylene Blue instead? Short answer: if you're wiped out, foggy, and not on an antidepressant, Methylene Blue is the more direct fix. If the actual problem is nerve damage or a long-game bet on neuroprotection, Humanin and ARA-290 are the better call, even though one of them is running on thinner human data than you'd like.

Two Tools, Two Completely Different Jobs

Here's the thing nobody says out loud before pitching you a comparison article: these three peptides aren't really competing for the same job. That's like asking whether you should hire a plumber or an electrician. Depends what's broken. And damn if people don't skip that question and just buy whatever's trending that week.

Humanin is a tiny 21-amino-acid peptide your own mitochondria make. Centenarians run HIGHER levels of it than the rest of us, and their kids do too. ARA-290 is the cleaned-up half of EPO, the hormone that boosts red blood cells, minus the part that boosts red blood cells. Yeah, I know how that sounds. Sounds backwards. It's true: Michael Brines and his team stripped EPO down to just the tissue-protective signal and left the blood-doping risk on the cutting room floor. What's left drives nerve regeneration without touching your hematocrit.

Methylene Blue does none of that. It's a 130-year-old dye that got repurposed into medicine, and at low doses it hands your mitochondria a shortcut around a clogged electron transport chain, the assembly line that turns food into usable energy. Fewer electrons leak, fewer free radicals get made, more ATP comes out the other end.

I've said this about a hundred times to clients who show up wanting the SHINY new peptide before they've nailed sleep, protein, and stress: you can't hang crown moldings on a house with no foundation. Neither of these compounds fixes a life where you sleep five hours and eat garbage. They're tools layered ON TOP of the basics, not a replacement for them. Get that right first.

The Evidence Gap Nobody Mentions

Here's where this gets honest instead of hypey. ARA-290 has an actual placebo-controlled human trial behind it: 48 type 2 diabetics, half on ARA-290, half on placebo, 28 days. Blood sugar improved. Nerve pain scores dropped. The corneal nerve fibers, about as hard an endpoint as you can measure without a biopsy, actually regrew more in the treatment group. That trial is also why ARA-290 carries FDA Orphan Drug status for a nerve condition tied to sarcoidosis. That's a REAL regulatory marker, not marketing fluff.

Humanin doesn't have that. Five hundred-plus published papers, a striking pattern in centenarians, solid mechanism work. Zero completed human trials as of today. NOTHING wrong with that, every peptide starts there, but it means you're betting on biology that's proven in petri dishes and old mice, not yet in people.

Methylene Blue sits in the middle. The mitochondrial mechanism is solid, animal studies show real memory gains in rats dosed with it, and the compound has decades of high-dose IV safety data from its FDA-approved emergency use. What it doesn't have is a controlled trial at the low daily oral dose people are actually using for brain fog and fatigue.

Now the part that actually decides this for a chunk of readers: Methylene Blue carries a REAL FDA warning, not a theoretical one, about mixing with SSRIs, SNRIs, and a long list of other serotonergic drugs. It can trigger serotonin syndrome, which has killed people in documented case reports. If you're on Zoloft, Lexapro, Prozac, or anything like them, Methylene Blue is off the table until you're off that drug under your prescriber's care. No debate needed. That single fact alone pushes a lot of people toward Humanin and ARA-290 by default.

There's a second hard stop worth knowing before you buy either compound. If you have G6PD deficiency, most common in people of Mediterranean, African, or Southeast Asian ancestry, Methylene Blue is off the table too, because it can trigger serious hemolytic anemia in that population. Source quality matters as well: run any vial through a certificate of analysis before you trust what's in it. Industrial-grade Methylene Blue, the aquarium and textile stuff, carries heavy metals that have nothing to do with the drug's real safety profile. USP-grade ONLY. Full stop.

So Which One Do You Actually Run

Ask yourself one question first: what's actually broken? Fatigue and brain fog with a normal nervous system? That's an electron-flow problem, and Methylene Blue is built for exactly that job. Diabetic-style nerve pain, tingling, numbness, or you're chasing longevity and you can stomach thinner human data for a bigger long-term bet? That's Humanin and ARA-290 territory.

On dosing: the trial that actually worked used ARA-290 at 4 mg subcutaneous, once a day, for 28 days straight. Some people run a lighter 0.5 to 1 mg maintenance dose after that, though that's community practice, not trial data. Humanin runs 1 to 3 mg two to three times a week, or 100 to 500 mcg of the more potent HNG version on the same schedule. Methylene Blue users typically start at 5 to 10 mg a day and work up toward 30 to 50 mg if they need more, taken in the morning so it doesn't wreck your sleep.

Now the part my lawyer makes me say, and honestly he's right: The doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.

One more thing I've noticed running this stuff by clients for years: people want a universal winner, and there isn't one. The nerve-damage guy and the burnt-out-brain-fog guy are not the same guy. Match the tool to the actual symptom, not to whichever one has the cooler backstory.

Here's the whole argument in one breath: real human trial data plus an FDA safety red line on one side, a compound your own body already makes plus a peptide engineered off a hormone you already understand on the other, with less human proof but no drug-interaction landmine. Pick the one that matches your actual problem, not the one that sounds cooler at the gym.

Thanks for reading. In health, Rick Gold